Tramadol/Celecoxib (Seglentis) for Pain
Tramadol/Celecoxib (Seglentis) for Pain
April 18, 2022 (Issue: 1648)
The FDA has approved Seglentis (Esteve/Kowa), an
oral combination of tramadol hydrochloride, a weak
opioid agonist and weak serotonin and norepinephrine
reuptake inhibitor (SNRI), and celecoxib, a COX-2
selective nonsteroidal anti-inflammatory...more
- C Almansa et al. Co-crystals as a new approach to multimodal analgesia and the treatment of pain. J Pain Res 2019; 12:2679.
- PE Bijur et al. A randomized trial comparing the efficacy of five oral analgesics for treatment of acute musculoskeletal extremity pain in the emergency department. Ann Emerg Med 2021; 77:345.
- Nonopioid drugs for pain. Med Lett Drugs Ther 2022; 64:33.
- S Videla et al. Pharmacokinetics of multiple doses of co-crystal of tramadol-celecoxib: findings from a four-way randomized open-label phase I clinical trial. Br J Clin Pharmacol 2018; 84:64.
- FDA Briefing Document. Joint meeting of Anesthetic and Analgesic Drug Products Advisory Committee and Drug Safety and Risk Management Advisory Committee. January 15, 2020. Available at https://bit.ly/3LwmcNi. Accessed March 31, 2022.
- J Lopez-Cedrun et al. Co-crystal of tramadol-celecoxib in patients with moderate to severe acute post-surgical oral pain: a dose-finding, randomised, double-blind, placebo- and active-controlled, multicentre, phase II trial. Drugs R D 2018; 18:137.
- LS Nelson and DN Juurlink. Tramadol and hypoglycemia: one more thing to worry about. JAMA Intern Med 2015; 175:194.
- Inhibitors and Inducers of CYP Enzymes, P-glycoprotein, and other transporters. Med Lett Drugs Ther 2021 October 20 (epub). Available at: medicalletter.org/downloads/CYP_PGP_Tables.pdf.
- VE Whiteman et al. Maternal opioid drug use during pregnancy and its impact on perinatal morbidity, mortality, and the costs of medical care in the United States. J Pregnancy 2014; 2014:906723.
- FDA warns against use of codeine and tramadol in children and breastfeeding women. Med Lett Drugs Ther 2017; 59:86.
- J Zipursky and DN Juurlink. The implausibility of neonatal opioid toxicity from breastfeeding. Clin Pharmacol Ther 2020; 108:964.
- Approximate WAC. WAC = wholesaler acquisition cost or manufacturer's published price to wholesalers; WAC represents a published catalogue or list price and may not represent an actual transactional price. Source: AnalySource® Monthly. March 5, 2022. Reprinted with permission by First Databank, Inc. All rights reserved. ©2022. www.fdbhealth.com/drug-pricing-policy.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.
Would you like to read the rest of this article? Gain access below.
Subscribe
Subscriptions to
The Medical Letter on Drugs and Therapeutics include:
- Print version published and mailed biweekly (26 issues/year)
- Unlimited online access to current and past issues (1988 - present)
- Mobile App
- FREE online per issue CME/CE
Purchase this article:
Title: Tramadol/Celecoxib (Seglentis) for Pain
Article code: 1648b
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
